Trial ID or NCT#

NCT02301624

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to determine if eculizumab is safe and effective for the treatment of patients with refractory gMG.

Investigator(s)

Srikanth Muppidi, MD

Contact us to find out if this trial is right for you.

CONTACT

Lesly Welsh